OTCPK:ARLZQ - Post by User
Comment by
dsilvermanon Nov 16, 2016 10:31am
89 Views
Post# 25468117
RE:RE:RE:Adams shouldn't sell ARLZ for less than $25/Share.
RE:RE:RE:Adams shouldn't sell ARLZ for less than $25/Share. Golden, how many drugs you know which got FDP approved but rejected in europe? I can't name even one. Regarding timelines, ARLZ should submit to EU before this year end, so possible approval should arrive until the end of 2017. Sounds great to me.